MiR-219 was described to be upregulated in AML with MLL-AF6 and MLL-AF9 versus other AML cases [41], while miR-589 was observed to be upregulated in MLL-rearranged AML versus normal controls [42]. This evidence concerns the gene KMT2A and acute myeloid leukemia.